The Austrian healthcare Biotech SME ProtAffin AG and the French Global Bioenergies are the joint winners of the Most Innovative Biotech SME Award 2012. EuropaBio names three other outstanding runners up: Green Biologics Ltd, from the UK, Promethera BioSciences from Belgium and to-BBB from the Netherlands. There were 37 applicants in total this year, coming from 17 member states.
ProtAffin AG developed more effective therapies for key global diseases as COPD, which affects 65 million people worldwide and is the fourth leading cause of death in the West.
Global Bioenergies developed more efficient ways to convert renewable resources into chemical building blocks and drop-in fuels, thereby drastically decreasing CO2 emissions.